Bal Pharma Limited (NSE:BALPHARMA)
India · Delayed Price · Currency is INR 92.01
-0.55 (-0.59%)
Aug 13, 2025, 3:30 PM IST
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.46 billion as of August 13, 2025. Its market cap has decreased by -15.97% in one year.
Market Cap
1.46B
Enterprise Value
2.88B
Revenue
2.95B
Ranking
n/a
PE Ratio
20.43
Stock Price
92.01
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.46B, an increase of 161.11%. That is a compound annual growth rate of 4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.46B | -24.73% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | 797.20M | 35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,859.09B |
| Divi's Laboratories | 1,590.69B |
| Cipla | 1,215.50B |
| Apollo Hospitals Enterprise | 1,043.73B |
| Mankind Pharma | 1,006.03B |
| Zydus Lifesciences | 961.51B |
| Fortis Healthcare | 695.05B |
| Aurobindo Pharma | 611.53B |